Kewaunee Scientific (KEQU) Cash from Financing Activities (2010 - 2026)

Kewaunee Scientific's Cash from Financing Activities history runs 17 years deep, the most recent figure standing at -$14.1 million for Q1 2026.

• In Q1 2026, Cash from Financing Activities fell 196.07% year-over-year to -$14.1 million; the TTM figure through Jan 2026 stood at -$20.7 million (down 301.5% YoY), while the FY2025 annual figure was $7.4 million, up 345.89% from the prior year.
• Cash from Financing Activities was -$14.1 million for Q1 2026 at Kewaunee Scientific, down from -$853000.0 in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $14.6 million in Q1 2025 to a low of -$14.1 million in Q1 2026.
• Historically, Cash from Financing Activities has averaged $419176.5 across 5 years, with a median of -$853000.0 in 2025.
• The sharpest annual moves came in 2023 and 2025: Cash from Financing Activities soared 639.31% in 2023, then plunged 526.53% in 2025.
• A 5-year view of Cash from Financing Activities shows it stood at -$145000.0 in 2022, then jumped by 639.31% to $782000.0 in 2023, then sank by 512.92% to -$3.2 million in 2024, then surged by 73.58% to -$853000.0 in 2025, then plunged by 1548.3% to -$14.1 million in 2026.
• The last three Cash from Financing Activities figures came in at -$14.1 million (Q1 2026), -$853000.0 (Q4 2025), and -$1.5 million (Q3 2025), per Business Quant data.